bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.06.749652

An RGS5-positive fibroblast to WNT-like epithelial TGFB axis in colorectal liver metastasis, replicated in an independent paired cohort

Abstract

Background: Colorectal cancer liver metastasis is accompanied by coordinated stromal remodelling, but which fibroblast and malignant epithelial states are coupled, and whether any such coupling holds outside the dataset it was found in, is rarely tested. Methods: Paired primary tumours and liver metastases from six patients were analysed by single-cell RNA sequencing with copy-number-based identification of malignant cells, trajectory inference, cell-cell communication and ligand-target modelling, and spatial transcriptomics of three metastatic sections. Protein staining was taken from an independent tissue resource. Every step was then repeated in a second, independent paired cohort of five patients and two further metastatic sections, with cell identities fixed by transfer from the discovery data rather than refitted. Results: An RGS5-positive fibroblast/pericyte-like state (F2) and a WNT-like malignant epithelial state (C2) were both enriched in metastases and occupied late trajectory positions. Communication analysis nominated a directional F2-to-C2 programme with transforming growth factor beta as the highest-ranked pathway and its receptor TGFBR2 enriched in C2. Spatial data placed the two states in the same neighbourhoods. Hub genes of the programme were TPT1, SLC1A5, SOX4 and TSC22D1, and protein staining was higher in tumour than normal colon for the three with available data. In the independent cohort the same states reappeared: F2 was enriched in metastases (Ro/E 1.22 versus 0.52; 32% versus 14% of fibroblasts), C2-like cells were the most metastasis-enriched epithelial state (1.10 versus 0.86), 92% of the cells that cohort's own authors called MCAM-positive fibroblasts mapped to F2, and F2 was again the strongest TGFB sender to C2-like epithelium at both sites. Conclusions: A directional TGFB axis from an RGS5-positive fibroblast state to a WNT-like epithelial state is a reproducible feature of colorectal liver metastasis rather than a property of one dataset. Its spatial expression varies between sections, which constrains how tightly the two states can be said to be co-localised.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yu, Y., Ma, F.. 2026-09-10. An RGS5-positive fibroblast to WNT-like epithelial TGFB axis in colorectal liver metastasis, replicated in an independent paired cohort. https://doi.org/10.64898/2026.09.06.749652

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells

Pancreatic ductal adenocarcinoma (PDAC) progression involves malignant cell state plasticity. Epigenetic changes underlie this plasticity, yet the PDAC cis-regulatory landscape remains understudied. To address this, we profiled 33 primary tumors and 7 metastases from 39 patients with single-cell ATAC-seq, paired with 10 single-cell RNA-seq profiles. We found that epigenetic GATA6+/KRT17+ co-accessibility identifies a classical-basal subtype-intermediate progenitor state (SIP) associated with better clinical outcomes. SIP cells display limited epigenetic reprogramming from premalignant epithelium and retain gastric-intestinal differentiation reminiscent of neoplastic precursors. Lineages without GATA6+/KRT17+ co-accessibility exhibit greater lineage and epithelial-mesenchymal plasticity. Classical PDACs that repress basal gene accessibility activate neural-like progenitor (NRP) and tuft lineage enhancers, whereas basal committed tumors display esophageal transdifferentiation. Compared to SIP, classical-NRP and basal committed tumors have poorer outcomes, and show distinct PD-1/PD-L1 immune proteomic phenotypes and prognostic myofibroblast epigenetic states, respectively. Our work reveals links between lineage reprogramming, EMT, and epigenetic progression in human PDAC.

cancer biology↗

Tissue resident CD4+ memory T-cells mark response to immune checkpoint inhibition in high-grade glioma

Background: Immune checkpoint inhibitors (ICI) are efficacious in many solid tumors, but response in glioma is restricted to a small subgroup. The determinants of response and resistance to ICI remain poorly understood. Methods: Here we exploit a syngeneic hypermutated high-grade glioma model with dichotomous response to combined PD-1 and CTLA-4 inhibition to unravel determinants of tumor-infiltrating T-cells driving response. Tumor-infiltrating T-cells from ICI-responsive and non-responsive tumors were analyzed by single-cell RNA and T-cell receptor sequencing and tumor-reactive T-cell receptor clonotypes were functionally validated to characterize their transcriptional phenotypes. We verify our findings in IDH1 wildtype glioblastoma patients treated with neoadjuvant pembrolizumab. Results: ICI response was associated with intratumoral clonal expansion of tumor-reactive cytotoxic T-cells and increased infiltration of CXCR6+ CD4+ tissue resident memory T-cells (Trm). CD4 stem-like memory T-cells in responding tumors demonstrated elevated interferon responses, following trajectories toward clonally expanded Trm, versus trajectories toward exhaustion in non-responsive tumors. In responsive tumors, CD4+ Trm interacted with infiltrating CXCR3+ tumor-reactive and clonally expanded, yet transcriptionally versatile cytotoxic T-cells. Probing the post neoadjuvant ICI high-grade glioma patient tissue dataset, we confirmed increased CXCR6 expression in CD4+ T cells and the association of CD4+ Trm with prolonged overall survival. Conclusion: These findings identify CD4 tissue-resident memory T-cells as determinants of ICI response in IDH1 wildtype high-grade glioma and warrant their further investigation to improve immunotherapy outcomes.

cancer biology↗

Low-dose doxorubicin drives caveolin-1 depended re-epithelialization of breast cancer cells as a mechanism of cancer plasticity

Breast cancer progression is driven by dynamic changes in epithelial plasticity, membrane organization, and intracellular signaling, yet the effects of sustained low-dose chemotherapy on these processes remain poorly understood. Here, we investigated the impact of prolonged low-dose doxorubicin on membrane remodeling, epithelial phenotype, membrane-associated Ras lipid-anchor localization, and autophagy in mesenchymal-like MDA-MB-231 breast cancer cells. Low-dose doxorubicin significantly increased Caveolin-1 expression and enhanced E-cadherin protein levels, accompanied by a transition toward a more compact epithelial-like morphology with increased cell-cell contacts. Live-cell imaging demonstrated a significant reduction in the membrane-to-cytoplasm fluorescence ratio of the lipid-anchored GFP-tH probe, indicating redistribution from the plasma membrane to the cytoplasm following treatment. Analysis of autophagy-related proteins revealed decreased LC3-I together with increased LC3-II, ATG5, and p62 expression, consistent with autophagosome accumulation and impaired autophagic flux. Collectively, our findings demonstrate that low-dose doxorubicin promotes extensive remodeling of plasma membrane organization, epithelial plasticity, membrane-associated lipid-anchor localization, and autophagy. This integrated response reveals previously unrecognized links between membrane architecture, Ras membrane association, and autophagy during phenotypic reprogramming of breast cancer cells, providing mechanistic insight into cellular adaptations elicited by sub-cytotoxic doxorubicin exposure.

cancer biology↗